522 related articles for article (PubMed ID: 16275763)
21. [Epigenetic regulation during osteoclastogenesis].
Youn MY; Kato S; Imai Y
Clin Calcium; 2012 May; 22(5):611-7. PubMed ID: 22549184
[TBL] [Abstract][Full Text] [Related]
22. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
[TBL] [Abstract][Full Text] [Related]
23. ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1.
Rohatgi N; Zou W; Collins PL; Brestoff JR; Chen TH; Abu-Amer Y; Teitelbaum SL
Blood Adv; 2018 Oct; 2(19):2467-2477. PubMed ID: 30266822
[TBL] [Abstract][Full Text] [Related]
24. Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation.
Negishi-Koga T; Takayanagi H
Immunol Rev; 2009 Sep; 231(1):241-56. PubMed ID: 19754901
[TBL] [Abstract][Full Text] [Related]
25. The role of the BH3-only protein Noxa in bone homeostasis.
Idrus E; Nakashima T; Wang L; Hayashi M; Okamoto K; Kodama T; Tanaka N; Taniguchi T; Takayanagi H
Biochem Biophys Res Commun; 2011 Jul; 410(3):620-5. PubMed ID: 21689638
[TBL] [Abstract][Full Text] [Related]
26. NFAT expression in human osteoclasts.
Day CJ; Kim MS; Lopez CM; Nicholson GC; Morrison NA
J Cell Biochem; 2005 May; 95(1):17-23. PubMed ID: 15759284
[TBL] [Abstract][Full Text] [Related]
27. RANKL-induced schlafen2 is a positive regulator of osteoclastogenesis.
Lee NK; Choi HK; Yoo HJ; Shin J; Lee SY
Cell Signal; 2008 Dec; 20(12):2302-8. PubMed ID: 18796328
[TBL] [Abstract][Full Text] [Related]
28. Induction of estrogen receptor alpha expression with decoy oligonucleotide targeted to NFATc1 binding sites in osteoblasts.
Penolazzi L; Zennaro M; Lambertini E; Tavanti E; Torreggiani E; Gambari R; Piva R
Mol Pharmacol; 2007 Jun; 71(6):1457-62. PubMed ID: 17389747
[TBL] [Abstract][Full Text] [Related]
29. MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner.
Miyamoto K; Ninomiya K; Sonoda KH; Miyauchi Y; Hoshi H; Iwasaki R; Miyamoto H; Yoshida S; Sato Y; Morioka H; Chiba K; Egashira K; Suda T; Toyama Y; Miyamoto T
Biochem Biophys Res Commun; 2009 Jun; 383(3):373-7. PubMed ID: 19364494
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
[TBL] [Abstract][Full Text] [Related]
31. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells.
Yagi M; Miyamoto T; Sawatani Y; Iwamoto K; Hosogane N; Fujita N; Morita K; Ninomiya K; Suzuki T; Miyamoto K; Oike Y; Takeya M; Toyama Y; Suda T
J Exp Med; 2005 Aug; 202(3):345-51. PubMed ID: 16061724
[TBL] [Abstract][Full Text] [Related]
32. Systems level analysis of osteoclastogenesis reveals intrinsic and extrinsic regulatory interactions.
Kiesel J; Miller C; Abu-Amer Y; Aurora R
Dev Dyn; 2007 Aug; 236(8):2181-97. PubMed ID: 17584858
[TBL] [Abstract][Full Text] [Related]
33. Impaired mast cell-driven immune responses in mice lacking the transcription factor NFATc2.
Becker M; Heib V; Klein M; Doener F; Bopp T; Taube C; Radsak M; Schild H; Schmitt E; Stassen M
J Immunol; 2009 May; 182(10):6136-42. PubMed ID: 19414766
[TBL] [Abstract][Full Text] [Related]
34. TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts.
Masuyama R; Vriens J; Voets T; Karashima Y; Owsianik G; Vennekens R; Lieben L; Torrekens S; Moermans K; Vanden Bosch A; Bouillon R; Nilius B; Carmeliet G
Cell Metab; 2008 Sep; 8(3):257-65. PubMed ID: 18762026
[TBL] [Abstract][Full Text] [Related]
35. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.
Lee SH; Rho J; Jeong D; Sul JY; Kim T; Kim N; Kang JS; Miyamoto T; Suda T; Lee SK; Pignolo RJ; Koczon-Jaremko B; Lorenzo J; Choi Y
Nat Med; 2006 Dec; 12(12):1403-9. PubMed ID: 17128270
[TBL] [Abstract][Full Text] [Related]
36. Treg cells suppress osteoclast formation: a new link between the immune system and bone.
Zaiss MM; Axmann R; Zwerina J; Polzer K; Gückel E; Skapenko A; Schulze-Koops H; Horwood N; Cope A; Schett G
Arthritis Rheum; 2007 Dec; 56(12):4104-12. PubMed ID: 18050211
[TBL] [Abstract][Full Text] [Related]
37. The calcineurin-NFAT pathway and bone: intriguing new findings.
Stern PH
Mol Interv; 2006 Aug; 6(4):193-6. PubMed ID: 16960140
[TBL] [Abstract][Full Text] [Related]
38. Protective role of nuclear factor of activated T cells 2 in CD8+ long-lived memory T cells in an allergy model.
Karwot R; Maxeiner JH; Schmitt S; Scholtes P; Hausding M; Lehr HA; Glimcher LH; Finotto S
J Allergy Clin Immunol; 2008 Apr; 121(4):992-9.e6. PubMed ID: 18329088
[TBL] [Abstract][Full Text] [Related]
39. RANKL-stimulated TNFalpha production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathways.
Nakao A; Fukushima H; Kajiya H; Ozeki S; Okabe K
Biochem Biophys Res Commun; 2007 Jun; 357(4):945-50. PubMed ID: 17467668
[TBL] [Abstract][Full Text] [Related]
40. [Epigenetic regulation of osteoclastogenesis by histone modification].
Omata Y; Tanaka S
Clin Calcium; 2012 May; 22(5):619-28. PubMed ID: 22549185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
